Johns Hopkins University Micrographic Surgery and Dermatologic Oncology

Topics

• Autoimmune Bullous Skin Diseases 159
• Dermatology and Skin Diseases 90
• Cancer Immunotherapy and Biomarkers 89
• Skin Protection and Aging 77
• Acne and Rosacea Treatments and Effects 71
• Hair Growth and Disorders 66
• Cutaneous lymphoproliferative disorders research 64
• Cutaneous Melanoma Detection and Management 59
• Dermatologic Treatments and Research 34
• Psoriasis: Treatment and Pathogenesis 28
• Nonmelanoma Skin Cancer Studies 25
• Cancer and Skin Lesions 17

Most cited

1. Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.

   The New England journal of medicine · 2022 · 2,432 citations · Janis Taube

2. Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer.

   The New England journal of medicine · 2023 · 710 citations · Janis Taube

3. Perioperative Nivolumab in Resectable Lung Cancer.

   The New England journal of medicine · 2024 · 495 citations · Janis Taube

4. Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer.

   The New England journal of medicine · 2025 · 201 citations · Janis Taube

5. Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers.

   Nature · 2021 · 464 citations · Janis Taube

6. Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma.

   The New England journal of medicine · 2022 · 277 citations · Janis Taube

7. Association between pathologic response and survival after neoadjuvant therapy in lung cancer.

   Nature medicine · 2024 · 171 citations ·